$7.59
0.060.8%
In chiusura: Nov 20, 4:00 PM EST
$1.65
-5.95-78.33%
Post-mercato: 7:59 PM EST

The average analyst price target for Capricor Therapeutics is $29.81, 1712.2% above the current price. Of 9 analysts, 7 rate it Buy and 2 Hold. Targets range from $10.50 to $54. The latest change came on Nov 13, 2026, when Roth Capital raised its price target on Capricor Therapeutics from $7 to $10.50 and kept a Neutral rating.
Price Target Range — 12 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months